A Registry for Patients With Multifocal Ground Glass Opacities (GGOs)



Status:Recruiting
Healthy:No
Age Range:19 - Any
Updated:1/16/2019
Start Date:January 9, 2019
End Date:January 2022
Contact:James Huang, MD
Email:huangj@mskcc.org
Phone:212-639-2530

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Thoracic Surgery Oncology Group (TSOG) Protocol: Registry Trial of Active Surveillance for Multifocal Ground Glass Opacities (GGOs)

The purpose of this registry study is to actively monitor people with GGOs and collect
information about them, so that investigators can learn more about these lesions and about
the risk of developing lung cancer in study participants whose GGOs are being monitored in
the active surveillance program.


Inclusion Criteria:

- Age greater than 18 years

- Have two or more GGO on CT imaging

- GGOs must be ≤3 cm in the greatest dimension

- GGOs must be greater than half ground glass

Exclusion Criteria:

- Patients who are actively undergoing lung cancer treatment or have a history of such
treatment, except for cases of completely resected pathologic stage IA nonsmall cell
lung cancer (NSCLC). Patients with stage IA NSCLC and multiple GGOs can enroll in this
active surveillance protocol after complete resection of the NSCLC and confirmation of
stage on final pathologic assessment.

- Patients being actively treated for other malignancies (not including lung cancer) or
who have previously been treated for other malignancies and have been cancer-free for
<3 years before study registration.
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: James Huang, MD
Phone: 212-639-2530
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials